Sarepta Therapeutics News

Oppenheimer Sticks to Their Buy Rating for Sarepta Therapeutics (SRPT)

TipRanksJul 24 08:31 ET

Oppenheimer Maintains Sarepta Therapeutics(SRPT.US) With Buy Rating, Cuts Target Price to $215

Moomoo NewsJul 24 08:31 ET

Buy Rating Affirmed for Sarepta Therapeutics Amid Strong Elevidys Demand and Strategic Growth Outlook

TipRanksJul 18 03:19 ET

Solid Biosciences up 10% Following J.P. Morgan Upgrade

Seeking AlphaJul 15 14:50 ET

Sarepta Therapeutics Analyst Ratings

BenzingaJul 1 09:54 ET

Sarepta Therapeutics (SRPT) Gets a Buy From Piper Sandler

TipRanksJul 1 06:37 ET

Needham Reiterates Buy on Sarepta Therapeutics, Maintains $235 Price Target

BenzingaJun 27 06:07 ET

Sarepta Therapeutics Analyst Ratings

BenzingaJun 26 10:28 ET

RBC Raises Price Target on Sarepta Therapeutics to $182 From $142, Maintains Sector Perform Rating

MT NewswiresJun 21 06:48 ET

Sarepta Therapeutics Analyst Ratings

BenzingaJun 21 06:10 ET

Sarepta Therapeutics Analyst Ratings

BenzingaJun 14 11:20 ET

Sarepta Therapeutics Analyst Ratings

BenzingaMay 31 06:01 ET

Analysts' Top Healthcare Picks: Biohaven Ltd. (BHVN), Sarepta Therapeutics (SRPT)

TipRanksMay 28 21:20 ET

RBC Capital Cuts Sarepta to Sector Perform Ahead of FDA Decision

Seeking AlphaMay 28 13:34 ET

Sarepta Therapeutics Analyst Ratings

BenzingaMay 28 06:14 ET

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH) and Sarepta Therapeutics (SRPT)

TipRanksMay 22 06:05 ET

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and Sol-Gel Technologies (SLGL)

TipRanksMay 20 06:45 ET

Sarepta Therapeutics Analyst Ratings

BenzingaMay 20 06:31 ET

Sarepta Therapeutics Analyst Ratings

BenzingaMay 17 07:44 ET

Buy Rating for Sarepta Therapeutics' Elevidys Supported by Positive Regulatory Signals

TipRanksMay 16 21:30 ET